Select Medical Holdings Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Select Medical Holdings de 11.9% y 5% por año respectivamente. Se prevé que el BPA crezca en un 5.7% al año. Se espera que la rentabilidad financiera sea de 12.2% en 3 años.

Información clave

11.9%

Tasa de crecimiento de los beneficios

5.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	27.6%
Tasa de crecimiento de los ingresos	5.0%
Rentabilidad financiera futura	12.2%
Cobertura de analistas	Low
Última actualización	18 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

DB:S24 - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	7,808	333	N/A	N/A	3
12/31/2025	7,365	414	N/A	N/A	5
12/31/2024	7,052	375	N/A	N/A	5
9/30/2024	6,969	266	353	572	N/A
6/30/2024	6,873	259	288	507	N/A
3/31/2024	6,788	260	241	464	N/A
12/31/2023	6,664	235	353	582	N/A
9/30/2023	6,587	217	191	415	N/A
6/30/2023	6,489	196	177	393	N/A
3/31/2023	6,399	174	128	330	N/A
12/31/2022	6,334	153	94	285	N/A
9/30/2022	6,312	175	21	212	N/A
6/30/2022	6,278	223	19	216	N/A
3/31/2022	6,258	329	-20	168	N/A
12/31/2021	6,205	389	221	401	N/A
9/30/2021	6,105	415	503	669	N/A
6/30/2021	5,995	415	553	705	N/A
3/31/2021	5,664	306	1,077	1,224	N/A
12/31/2020	5,532	250	882	1,028	N/A
9/30/2020	5,446	206	860	999	N/A
6/30/2020	5,415	162	859	998	N/A
3/31/2020	5,544	155	300	448	N/A
12/31/2019	5,454	143	288	445	N/A
9/30/2019	5,344	136	210	380	N/A
6/30/2019	5,218	138	235	410	N/A
3/31/2019	5,153	140	308	485	N/A
12/31/2018	5,081	133	327	494	N/A
9/30/2018	4,911	207	309	489	N/A
6/30/2018	4,720	193	N/A	415	N/A
3/31/2018	4,527	189	N/A	345	N/A
12/31/2017	4,365	171	N/A	238	N/A
9/30/2017	4,300	93	N/A	196	N/A
6/30/2017	4,259	82	N/A	209	N/A
3/31/2017	4,237	74	N/A	180	N/A
12/31/2016	4,217	112	N/A	347	N/A
9/30/2016	4,211	121	N/A	286	N/A
6/30/2016	4,178	143	N/A	312	N/A
3/31/2016	3,973	146	N/A	282	N/A
12/31/2015	3,683	127	N/A	208	N/A
9/30/2015	3,420	123	N/A	222	N/A
6/30/2015	3,165	121	N/A	204	N/A
3/31/2015	3,052	119	N/A	224	N/A
12/31/2014	3,020	117	N/A	171	N/A
9/30/2014	2,997	121	N/A	230	N/A
6/30/2014	2,963	118	N/A	213	N/A
3/31/2014	2,949	111	N/A	188	N/A
12/31/2013	2,938	112	N/A	193	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (11.9% al año) de S24 es superior a la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que los beneficios (11.9% al año) de S24 crezcan menos que el mercado German (21.1% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de S24 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (5% al año) de S24 crezcan más despacio que el mercado de German (5.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5% al año) de S24 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de S24 sea baja dentro de 3 años (12.2%).

Select Medical Holdings Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Select Medical Reaffirms Earnings Guidance for the Year 2024

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Provides Revenue Guidance for the Year 2022

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ended December 31, 2021

Recent updates

Insufficient new directors

Investor sentiment improves as stock rises 16%

Third quarter dividend of US$0.13 announced

Third quarter 2024 earnings released: EPS: US$0.43 (vs US$0.38 in 3Q 2023)

Select Medical Holdings Corporation Updates Earnings Guidance for the Year Ending December 31, 2024

Select Medical Holdings Corporation to Report Q3, 2024 Results on Oct 31, 2024

New major risk - Revenue and earnings growth

Second quarter dividend of US$0.13 announced

Second quarter 2024 earnings released: EPS: US$0.60 (vs US$0.61 in 2Q 2023)

Select Medical Holdings Corporation Declares a Cash Dividend, Payable on or About August 30, 2024

Select Medical Holdings Corporation to Report Q2, 2024 Results on Aug 01, 2024

Investor sentiment improves as stock rises 18%

First quarter dividend of US$0.13 announced

New minor risk - Shareholder dilution

First quarter 2024 earnings released: EPS: US$0.75 (vs US$0.56 in 1Q 2023)

Select Medical Reaffirms Earnings Guidance for the Year 2024

Insufficient new directors

Select Medical Holdings Corporation to Report Q1, 2024 Results on May 02, 2024

Select Medical Holdings Corporation, Annual General Meeting, Apr 25, 2024

Fourth quarter dividend of US$0.13 announced

Full year 2023 earnings released: EPS: US$1.91 (vs US$1.23 in FY 2022)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About March 13, 2024

Select Medical Holdings Corporation to Report Q4, 2023 Results on Feb 22, 2024

Upcoming dividend of US$0.13 per share at 2.3% yield

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 28, 2023

Third quarter 2023 earnings released: EPS: US$0.38 (vs US$0.21 in 3Q 2022)

Select Medical Holdings Corporation to Report Q3, 2023 Results on Nov 02, 2023

Select Medical Holdings Corporation Announces Appointment of Michael Malatesta as Chief Financial Officer, Effective October 1, 2023

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or about September 1, 2023

Second quarter 2023 earnings released: EPS: US$0.61 (vs US$0.43 in 2Q 2022)

Select Medical Holdings Corporation Provides Earnings Guidance for the Second Quarter Ended June 30, 2023

Select Medical Holdings Corporation to Report Q2, 2023 Results on Aug 03, 2023

Select Medical Holdings Corporation(NYSE:SEM) dropped from Russell Small Cap Comp Value Index

Insider recently sold €268k worth of stock

Upcoming dividend of US$0.13 per share at 1.7% yield

Select Medical Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of 2023

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About May 31, 2023

First quarter 2023 earnings released: EPS: US$0.56 (vs US$0.37 in 1Q 2022)

Full year 2022 earnings released: EPS: US$1.23 (vs US$2.99 in FY 2021)

Select Medical Holdings Corporation to Report Q4, 2022 Results on Feb 23, 2023

Investor sentiment improved over the past week

Upcoming dividend of US$0.13 per share

Third quarter 2022 earnings released: EPS: US$0.21 (vs US$0.57 in 3Q 2021)

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About November 29, 2022

Select Medical Holdings Corporation to Report Q3, 2022 Results on Nov 03, 2022

Now 21% undervalued

Select Medical Holdings Corporation Declares Cash Dividend, Payable on or About September 2, 2022

Now 24% undervalued

Second quarter 2022 earnings released: EPS: US$0.43 (vs US$1.22 in 2Q 2021)

Select Medical Holdings Corporation to Report Q2, 2022 Results on Aug 04, 2022

Upcoming dividend of US$0.13 per share

First quarter 2022 earnings released: EPS: US$0.37 (vs US$0.82 in 1Q 2021)

Select Medical Holdings Corporation Announces Cash Dividend, Payable on or About June 1, 2022

Select Medical Holdings Corporation to Report Q1, 2022 Results on May 05, 2022

Select Medical Holdings Corporation (NYSE:SEM) acquired Six Critical Illness Recovery Hospitals.

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Select Medical Holdings Corporation Provides Revenue Guidance for the Year 2022

Investor sentiment deteriorated over the past week

Select Medical Holdings Corporation Provides Earnings Guidance for the Year Ended December 31, 2021

Third quarter 2021 earnings released: EPS US$0.57 (vs US$0.57 in 3Q 2020)

Independent Director recently sold €308k worth of stock

Upcoming dividend of US$0.13 per share

Second quarter 2021 earnings released: EPS US$1.22 (vs US$0.39 in 2Q 2020)

Select Medical Holdings Corporation Provides Earnings Outlook for the Full Year 2021

Select Medical Holdings Corporation (NYSE:SEM) completed the acquisition of AcuityHealthcare, LP.

Select Medical Holdings Corporation (NYSE:SEM) and Northwest Healthcare agreed to acquire Curahealth Tucson from Curahealth, LLC.

Independent Director recently sold €349k worth of stock

Insider recently sold €163k worth of stock

Insider recently sold €154k worth of stock